The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 06, 2018

Filed:

Jan. 29, 2016
Applicant:

Leidos, Inc., Reston, VA (US);

Inventors:

John Dresios, Carlsbad, CA (US);

Richard Holmes Griffey, Vista, CA (US);

Challise J. Sullivan, San Diego, CA (US);

Erik D. Pendleton, San Diego, CA (US);

Henri M. Sasmor, Oceanside, CA (US);

William L. Hicks, San Diego, CA (US);

Eric M. Amendt, San Diego, CA (US);

Assignee:

Leidos, Inc., Reston, VA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
B01D 15/36 (2006.01); B01D 15/14 (2006.01); C12M 1/12 (2006.01); C12N 9/12 (2006.01); C07K 14/505 (2006.01); C07K 14/535 (2006.01); C12M 1/40 (2006.01); C12M 1/00 (2006.01); C12M 1/36 (2006.01); C12M 3/00 (2006.01); B01D 15/12 (2006.01); B01D 15/10 (2006.01); B01D 15/22 (2006.01); B01D 15/38 (2006.01); B01D 15/34 (2006.01); C12P 21/02 (2006.01);
U.S. Cl.
CPC ...
B01D 15/361 (2013.01); B01D 15/10 (2013.01); B01D 15/12 (2013.01); B01D 15/14 (2013.01); B01D 15/22 (2013.01); B01D 15/34 (2013.01); B01D 15/3804 (2013.01); C07K 14/505 (2013.01); C07K 14/535 (2013.01); C12M 21/18 (2013.01); C12M 23/28 (2013.01); C12M 23/44 (2013.01); C12M 29/00 (2013.01); C12M 41/48 (2013.01); C12M 47/10 (2013.01); C12N 9/1223 (2013.01); C12N 9/1252 (2013.01); C12P 21/02 (2013.01); C12Y 207/03002 (2013.01); C12Y 207/07007 (2013.01);
Abstract

A portable fluidic platform for rapid and flexible end-to-end production of recombinant protein biologics includes a bioreactor system hosting stable and robust cell-free translation systems that is fluidically integrated with modular protein separation functionalities (e.g., size exclusion, ion exchange or affinity chromatography systems) for purification of the cell-free expressed product and which are configurable for process-specific isolation of different proteins, as well as for formulation. The bioreactor utilizes lysates from engineered eukaryotic (e.g., yeast) or prokaryotic (e.g., bacterial) strains that contain factors for protein folding and posttranslational modifications. Combination of various purification modules on the same fluidic platform allows flexibility of re-routing for purification of different proteins depending on specific target requirements. Protein synthesis and purification modules are integrated into self-contained disposable fluidic cartridge that eliminates cross-contamination between runs. The platform allows for flexible production of protein biologics within 24 hours (from DNA to purified product).


Find Patent Forward Citations

Loading…